>
pdufa.bio

XEN1701

Updated ยทnext FDA decision on the calendar

XEN1701 is a Xenon Pharmaceuticals Inc. program. Its next catalyst is a Readout in Q3 2026. Every date links its source.

XENE catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Xenon Pharmaceuticals Inc. (XENE). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Q3 2026XENE

Questions

When is XEN1701's next FDA decision or readout?

The next tracked catalyst for XEN1701 is a Readout in Q3 2026.

What happened at XEN1701's most recent FDA decision?

No FDA decision for XEN1701 is in our archive yet.

Who makes XEN1701?

Xenon Pharmaceuticals Inc. (XENE).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.